Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries.
about
Vaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useRotavirus vaccine for preventing diarrhoeaPerformance of rotavirus vaccines in developed and developing countriesRotavirus vaccines: targeting the developing world.Genetic diversity of circulating rotavirus strains in Tanzania prior to the introduction of vaccinationProtective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.Rotavirus Diarrhea among Children in Taiz, Yemen: Prevalence-Risk Factors and Detection of Genotypes.Global illness and deaths caused by rotavirus disease in children.Implementing new health interventions in developing countries: why do we lose a decade or more?Considerations for combination vaccine development and use in the developing world.Characteristics of diarrheal illnesses in non-breast fed infants attending a large urban diarrheal disease hospital in BangladeshSystemic rotavirus infection.Impact of rotavirus vaccine on premature infantsMolecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12.Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.Rotavirus particles can survive storage in ambient tropical temperatures for more than 2 months.Rotavirus vaccines--an update.Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3.Tropical disease vaccines.Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence.A prospective evaluation of community acquired gastroenteritis in paediatric practices: impact and disease burden of rotavirus infection.First report from the Asian Rotavirus Surveillance NetworkDevelopment and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.A critical time for rotavirus vaccines: a review.Clinical Symptoms of Human Rotavirus Infection Observed in Children in Sokoto, NigeriaBudget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy.Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007.Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies.Molecular Characterization of Human Rotavirus from Children with Diarrhoeal Disease in Sokoto State, NigeriaMedium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS).Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India.Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model.Introduction of rotavirus vaccines in developing countries: remaining challenges.Evaluating the safety of a rotavirus vaccine: the REST of the story.Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study.Economic impact of a rotavirus vaccine in Brazil.
P2860
Q24197495-C7DD18A5-1EB9-4660-85B8-B3C36E40C046Q24203645-60C0628A-0BD1-443C-9F1A-752CB1852F38Q24235411-F93CE138-0511-4B19-9357-78DF5625A9B8Q24247507-1459D2BB-6BA7-40FF-BA0F-0CABC96FEEA1Q24600612-5305EFAC-3252-4267-A2C2-CFAE6889A283Q30795376-5469D399-EB65-431E-B119-9C4796722550Q33638246-728FEAA8-C61E-4D18-8112-48C6AE926C78Q33845547-52E67F67-1831-457F-8085-8BE464770BA8Q33971446-5075F041-EB85-4C8B-889B-B2C7399DBC18Q34064371-B3632663-4B2F-4479-B1EF-73E0734ECB97Q34094018-8AB0B073-4B2F-49B8-8970-7331E83A7B69Q34275969-B3DBE377-55E7-4663-B049-C908BFAF5907Q34386553-36444E98-1EBF-459A-8DFA-00CA895F2DC5Q34440154-D8EB4161-1228-4B06-99FF-77978362B112Q34631764-1761BC20-E601-4D32-AE9A-160F50473F06Q34659711-10B47136-3809-45D8-BEA5-6DBDACB91C30Q34701370-20DF89E6-9265-4411-BAB2-BD02D1ECBC99Q34719642-060F1589-23E8-4D49-99DB-1A97F7CCBD5FQ34791255-129E8D7F-7C9B-4E87-938E-2874F3A4638BQ34988535-7E377222-348C-4108-922C-8D72BC1573B8Q35116158-426797AF-CD87-4A22-B1BA-6582354CA230Q35123345-1415BF3C-E065-4A9B-8A85-17D374C7853AQ35193556-C83F091B-133B-4C71-ADF2-EB491466F895Q35225171-497D9EB0-B3ED-428C-B21D-0D58381EF59FQ35270006-994A17AF-D71F-4D4C-BF5C-B6A1F4078386Q35810703-005E3E03-AB4B-448C-A173-AF1A134FC3EAQ35947518-16A4A921-74D2-40EB-97F1-D1DB30E6CA1BQ36238714-3D450C88-A0D1-43D0-8B3C-DB7002AD43CFQ36356521-0EBD036B-D200-442A-AD86-1BC631CF86EEQ36478415-63827AD7-AB1D-42AB-8826-317456AFA1C7Q36539869-E9BE6A7C-494A-4C56-8745-2A75FEBF23A9Q36550022-B3C89690-F7CE-436E-8A2F-5A69ECB8D037Q36718912-DC73B689-C648-473D-96A3-D5A6A41F12A2Q36739996-99D69387-5897-4AA7-B7A7-57C071A430BDQ36774675-A007F951-F344-45B7-A89B-68CD70E57638Q36788202-00CCF9BD-FE66-4C60-B662-9242A2C4FA6EQ36918275-D43D5BA9-FE41-4319-AE77-CF21F00ADEF9Q37014380-E1B9E090-E4FF-4F9E-B7D1-2A80A0434F5BQ37145731-299FB597-9EA0-4E32-840E-4AFAEA6D6059Q37339643-EDB5CF65-0421-42C8-9C89-CD2BE61F5EBF
P2860
Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current status and future prio ...... ation in developing countries.
@ast
Current status and future prio ...... ation in developing countries.
@en
type
label
Current status and future prio ...... ation in developing countries.
@ast
Current status and future prio ...... ation in developing countries.
@en
prefLabel
Current status and future prio ...... ation in developing countries.
@ast
Current status and future prio ...... ation in developing countries.
@en
P2093
P1433
P1476
Current status and future prio ...... ation in developing countries.
@en
P2093
P304
P356
10.1016/S0264-410X(98)00376-4
P407
P577
1999-05-01T00:00:00Z